BioPlus Acquisition
BIOS | NASDAQ
$10.79
-$0.01 (-0.09%)
At close: Oct 06, 2023, 03:46 PM ET
BioPlus Acquisition Company Profile
Company profile explainedCompany Profile
Currently, BioPlus Acquisition Corp. possesses no major active business operations. Its express mandate is to pursue and complete a strategic combination, which may take the form of a merger, share exchange, asset purchase, stock acquisition, reorganization, or similar transaction. This targeted consolidation is specifically aimed at one or more entities within the vibrant life sciences industry. The corporation was formally established in 2021 and maintains its principal executive offices in New York, New York.
Key Executives
| Name | Position |
|---|---|
| Ross Haghighat | Chief Executive Officer, Chief Financial Officer & Director |
BioPlus Acquisition
| Country | United States |
| IPO Date | Jan 28, 2022 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | R. Ross Haghighat |
Contact Details
260 Madison Avenue New York City,
New York 10026 United States
Stock Details
| Ticker Symbol | BIOS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001856653 |
| CUSIP Number | 09069N108 |
| ISIN Number | KYG112171171 |
| SIC Code | 6770 |
Add to Watchlist
Select watchlists to add or remove BIOS